Cantel Medical Corp. (CMN) CAO Sells $423,885.00 in Stock
Cantel Medical Corp. (NYSE:CMN) CAO Steven C. Anaya sold 5,500 shares of Cantel Medical Corp. stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $77.07, for a total transaction of $423,885.00. Following the transaction, the chief accounting officer now directly owns 48,132 shares in the company, valued at $3,709,533.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Cantel Medical Corp. (NYSE:CMN) traded up 0.30% on Wednesday, hitting $76.88. 118,110 shares of the stock were exchanged. The company’s 50 day moving average price is $77.65 and its 200-day moving average price is $71.18. Cantel Medical Corp. has a one year low of $53.64 and a one year high of $81.63. The company has a market cap of $3.18 billion, a P/E ratio of 53.46 and a beta of 1.59.
Cantel Medical Corp. (NYSE:CMN) last released its quarterly earnings data on Thursday, September 29th. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.11. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The firm had revenue of $179 million for the quarter. During the same quarter in the prior year, the company posted $0.39 EPS. The company’s quarterly revenue was up 18.3% on a year-over-year basis. Equities research analysts predict that Cantel Medical Corp. will post $1.98 EPS for the current fiscal year.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/cantel-medical-corp-cmn-cao-sells-423885-00-in-stock.html
A number of institutional investors have recently added to or reduced their stakes in the company. Acrospire Investment Management LLC increased its position in Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock worth $102,000 after buying an additional 500 shares in the last quarter. LS Investment Advisors LLC increased its position in Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock worth $104,000 after buying an additional 106 shares in the last quarter. BlackRock Inc. increased its position in Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock worth $168,000 after buying an additional 1,282 shares in the last quarter. Bank of Montreal Can purchased a new position in Cantel Medical Corp. during the second quarter worth approximately $203,000. Finally, Cypress Wealth Advisors LLC purchased a new position in Cantel Medical Corp. during the first quarter worth approximately $210,000. Hedge funds and other institutional investors own 81.60% of the company’s stock.
A number of research analysts have recently commented on CMN shares. Needham & Company LLC started coverage on shares of Cantel Medical Corp. in a research report on Wednesday, August 24th. They set a “hold” rating on the stock. Benchmark Co. started coverage on shares of Cantel Medical Corp. in a research report on Monday, August 29th. They set a “buy” rating and a $83.00 target price on the stock.
About Cantel Medical Corp.
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.